🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a multicenter, randomized, open-label, parallel-group phase I...
Status
Recruiting
Location
Beijing
Start Date
2025-09-23
Trial ID
NCT07150975
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled phase I...
Status
Active Not Recruiting
Location
Beijing
Start Date
2024-12-30
Trial ID
NCT06728124
This trial is a randomized, double-blind, three-period crossover Phase I Cl...
Status
Not Yet Recruiting
Location
Study site 01
Start Date
2025-05-08
Trial ID
NCT06974487
Treatments Being Tested
This study is a multicenter, randomized, double-blind, parallel, placebo-co...
Status
Not Yet Recruiting
Location
Gan & Lee Pharmaceuticals
Start Date
2026-04-27
Trial ID
NCT07493057
Treatments Being Tested
This study was a multicenter, randomized, parallel and controlled study in ...
Status
Unknown
Location
Gan & Lee Pharmaceuticals Co., Ltd
Start Date
2023-08-09
Trial ID
NCT06256549
Treatments Being Tested
The main purpose of this study is to investigate the Efficacy and Safety of...
Status
Active Not Recruiting
Location
Tianjin Medical University General Hospital
Start Date
2025-02-13
Trial ID
NCT06778967
Treatments Being Tested
This is a single-center, open-label, fixed-sequence phase I clinical study ...
Status
Recruiting
Location
Study site 01
Start Date
2025-11-17
Trial ID
NCT07128888
Treatments Being Tested
This is a multicenter, randomized, open-label, positive controlled efficacy...
Status
Active Not Recruiting
Location
Study site 01
Start Date
2025-08-07
Trial ID
NCT07055386
This is a single-center, open-label, fixed-sequence phase I clinical study ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-10-30
Trial ID
NCT06670209
Treatments Being Tested
This is a Phase 3 extension study conducted in subjects who have received G...
Status
Recruiting
Location
Study site 01
Start Date
2026-01-22
Trial ID
NCT07292441
Treatments Being Tested